Disease | psoriasis |
Symptom | C0239946|hepatic fibrosis |
Sentences | 2 |
PubMedID- 23065020 | In this study, we aimed to evaluate the effect of etanercept versus psoralen and uva (puva) therapy on the hepatic fibrosis risk in patients with psoriasis, metabolic syndrome, and nafld (with nafld diagnosed by ultrasonography). |
PubMedID- 23440555 | Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease. |
Page: 1